The acquisition is expected to close by the end of the third quarter.
Researchers have found that patients with celiac disease are at high risk of acquiring pneumonia if they haven't received the pneumococcal vaccine.
Vermont is poised to become the first state requiring drug companies to explain their price increases, and Bob and Deborah Messing think that's a good idea.
Red wine lovers have a new reason to celebrate.
The Philadelphia randomized control study placed 290 11- and 12-year-olds with a history of violence into four groups.
The company's announcement has limited immediate impact.
A team led by NIH scientists have reported a research trifecta.
The RESONATE-2 trial served as the basis for the March 2016 FDA approval of IMBRUVICA for the first-line treatment of CLL patients.
The research and educational collaboration will look particularly at applying next-generation sequencing to improve the health of communities.
A senior Republican lawmaker said Friday he'll unveil additional funding next week to battle the Zika virus in hopes of a quick vote in the GOP-controlled House.
A judge has unsealed records from a Kentucky lawsuit against the maker of the prescription painkiller OxyContin, including the secret testimony of a former company president.
GSK has a broad portfolio of approved meningococcal meningitis vaccines
The new research builds on an international clinical trial conducted 10 years ago.
Selumetinib inhibits the MEK pathway in cancer cells to prevent tumor growth.